CMV-MVA Triplex Vaccination of Stem Cell Donors in Preventing CMV Viremia in Participants With Allogeneic Transplant

Clinical trial NCT03560752 · ACTIVE_NOT_RECRUITING

Trial details

NCT number: NCT03560752
Sponsor: City of Hope Medical Center
Status: ACTIVE_NOT_RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Accelerated Phase CML, BCR-ABL1 Positive Acute Lymphoblastic Leukemia in Remission Acute Myeloid Leukemia in Remission Chronic Lymphocytic Leukemia Chronic Phase CML, BCR-ABL1 Positive Cytomegalovirus Positive Donor Hematopoietic Cell Transplant Recipient Hodgkin Lymphoma Myelodysplastic Syndrome Myelodysplastic/Myeloproliferative Neoplasm Non-Hodgkin Lymphoma

Start date: 2018-08-20
Primary completion: 2022-01-22
Enrollment: 34

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.